Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dale

Showing results (331-340 of 348) with videos related to

Pageof 35
Sort By:
The Pediatric Infectious Disease Journal|November 22, 2016
The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in ChildrenMark E Engel, Karen Cohen, Ronald Gounden, et al.
Cell|May 15, 2018
Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive InfectionFelipe A Pinho-Ribeiro, Buket Baddal, Rianne Haarsma, et al.
Leukemia & Lymphoma|December 29, 2004
A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphomaJ J Biagi, K E Herbert, C Smith, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I studyÉlodie Pastural, Shelly A McNeil, Donna MacKinnon-Cameron, et al.
Clinical and Vaccine Immunology : CVI|July 25, 2014
A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococciAniela Wozniak, Patricia García, Enrique A Geoffroy, et al.
Clinical and Vaccine Immunology : CVI|January 30, 2015
Protective immunogenicity of group A streptococcal M-related proteinsJames B Dale, Shannon E Niedermeyer, Tina Agbaosi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2023
Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing MonitoringEdwin J Asturias, Jean-Louis Excler, James Ackland, et al.
The Pediatric Infectious Disease Journal|October 31, 2014
Streptococcal pharyngitis in schoolchildren in Bamako, MaliMilagritos D Tapia, Samba O Sow, Boubou Tamboura, et al.
Vaccine|April 20, 2013
Group A streptococcal vaccines: paving a path for accelerated developmentJames B Dale, Vincent A Fischetti, Jonathan R Carapetis, et al.
The New England Journal of Medicine|April 14, 2016
Two-Year Costs and Quality in the Comprehensive Primary Care InitiativeStacy B Dale, Arkadipta Ghosh, Deborah N Peikes, et al.
Pageof 35

Showing results (331-340 of 348) with videos related to

Sort By:
Pageof 35
The Pediatric Infectious Disease Journal|November 22, 2016
The Cape Town Clinical Decision Rule for Streptococcal Pharyngitis in ChildrenMark E Engel, Karen Cohen, Ronald Gounden, et al.
Cell|May 15, 2018
Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive InfectionFelipe A Pinho-Ribeiro, Buket Baddal, Rianne Haarsma, et al.
Leukemia & Lymphoma|December 29, 2004
A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphomaJ J Biagi, K E Herbert, C Smith, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I studyÉlodie Pastural, Shelly A McNeil, Donna MacKinnon-Cameron, et al.
Clinical and Vaccine Immunology : CVI|July 25, 2014
A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococciAniela Wozniak, Patricia García, Enrique A Geoffroy, et al.
Clinical and Vaccine Immunology : CVI|January 30, 2015
Protective immunogenicity of group A streptococcal M-related proteinsJames B Dale, Shannon E Niedermeyer, Tina Agbaosi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2023
Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing MonitoringEdwin J Asturias, Jean-Louis Excler, James Ackland, et al.
The Pediatric Infectious Disease Journal|October 31, 2014
Streptococcal pharyngitis in schoolchildren in Bamako, MaliMilagritos D Tapia, Samba O Sow, Boubou Tamboura, et al.
Vaccine|April 20, 2013
Group A streptococcal vaccines: paving a path for accelerated developmentJames B Dale, Vincent A Fischetti, Jonathan R Carapetis, et al.
The New England Journal of Medicine|April 14, 2016
Two-Year Costs and Quality in the Comprehensive Primary Care InitiativeStacy B Dale, Arkadipta Ghosh, Deborah N Peikes, et al.
Pageof 35